Abstract
We propose a novel clinical construct, the “Gulliver syndrome”, to describe the scenario in which multiple, mildly elevated cardiovascular risk factors (CVRFs) coexist within an individual and together result in a significantly heightened overall risk of cardiovascular disease (CVD). This accumulation of small deviations, often dismissed in clinical practice, can exert a synergistic impact on vascular health. Our aim is to formalize this underrecognized phenotype, which falls outside traditional diagnostic entities such as the metabolic syndrome, and to provide a framework that enables early recognition and management. We outline proposed diagnostic criteria, contrast this syndrome with related constructs, support its clinical relevance with emerging literature, and present a representative case. Ultimately, we advocate for this framework as a tool to overcome therapeutic inertia and encourage proactive, multifactorial interventions in primary and preventive care.
| Original language | English |
|---|---|
| Article number | 1652447 |
| Journal | Frontiers in Cardiovascular Medicine |
| Volume | 12 |
| DOIs | |
| State | Published - 2025 |
Keywords
- biomarkers
- cholesterol
- diabetes mellitus
- hypertension
- obesity
Fingerprint
Dive into the research topics of 'The Gulliver syndrome: a conceptual framework to address therapeutic inertia in patients with borderline cardiovascular risk profiles'. Together they form a unique fingerprint.Press/Media
-
-
-
Síndrome de Gulliver: el nuevo paradigma que podría cambiar la forma en que prevenimos enfermedades del corazón
19/08/25
1 Media contribution
Press/Media